​

Neumora Therapeutics Ownership | Who Owns Neumora Therapeutics?


OverviewForecastFinancialsChartTranscripts

Neumora Therapeutics Ownership Summary


Neumora Therapeutics is owned by 62.99% institutional investors, 25.33% insiders, and 11.69% retail investors. Siren is the largest institutional shareholder, holding 4.59% of NMRA shares. Vanguard Morn Total Stk Mkt Idx Investor is the top mutual fund, with 1.88% of its assets in Neumora Therapeutics shares.

NMRA Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockNeumora Therapeutics62.99%25.33%11.69%
SectorHealthcare Stocks 129.40%12.08%-41.48%
IndustryBiotech Stocks 181.71%11.69%-93.40%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Siren8.50M4.59%$5.07M
Blackrock funding, inc. /de8.14M4.40%$4.85M
Softbank group6.09M3.73%$11.88M
Vanguard group4.54M2.80%$8.13M
Vanguard capital management4.67M2.52%$2.78M
Affinity asset advisors4.50M2.43%$2.68M
Mic capital management uk llp4.46M2.41%$2.66M
Exor4.22M2.28%$2.51M
Wellcome trust ltd (the) as trustee of the wellcome trust3.31M1.79%$1.97M
Millennium management2.75M1.69%$5.37M

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Mic capital management uk llp4.46M0.57%$2.66M
Stonepine capital management787.27K0.29%$469.37K
Ikarian capital1.28M0.20%$2.49M
Addis & hill163.39K0.19%$318.60K
Lunate capital2.12M0.18%$1.27M
Johnson & johnson1.85M0.14%$1.10M
Siren8.50M0.12%$5.07M
Iconiq capital2.56M0.11%$4.99M
Affinity asset advisors4.50M0.11%$2.68M
Softbank group6.09M0.10%$11.88M

Top Buyers

HolderShares% AssetsChange
Affinity asset advisors4.50M0.11%3.43M
Qube research952.05K0.00%926.96K
Ubs group961.70K0.00%817.98K
Stonepine capital management787.27K0.29%787.27K
Tudor investment corp et al771.42K0.00%771.42K

Top Sellers

HolderShares% AssetsChange
Perceptive advisors---5.10M
Capital investors---3.70M
Ecor1 capital---2.07M
Baker bros. advisors lp---1.03M
Adage capital partners gp---1.00M

New Positions

HolderShares% AssetsChangeValue
Tudor investment corp et al771.42K0.00%771.42K$1.50M
Caption management412.20K0.00%412.20K$803.79K
Los angeles capital management404.33K0.00%404.33K$241.06K
Empowered funds221.22K0.00%221.22K$131.89K
Velan capital investment management lp80.00K0.10%80.00K$156.00K

Sold Out

HolderChange
Gamma investing-16.00
Ifp advisors-32.00
Ronald blue trust-38.00
Lindbrook capital-48.00
Corecap advisors-57.00

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Sep 30, 2026118-4.07%116,624,89851.83%623.66%51-23.88%3454.55%
Jun 30, 20261231.65%76,813,5349.13%412.71%6510.17%24-22.58%
Mar 31, 202649-53.77%22,411,846-64.48%130.90%23-58.18%10-56.52%
Dec 31, 202565-35.00%32,985,290-34.97%202.07%29-12.12%14-65.00%
Sep 30, 202598-4.85%49,889,004-11.08%302.56%32-38.46%3930.00%

Top Mutual Funds Shareholders


HolderShares% HoldingChange
Vanguard Morn Total Stk Mkt Idx Investor3.44M1.88%639.40K
Vanguard Total Stock Mkt Idx Inv3.44M1.88%639.40K
Vanguard MStar Total Stk Mkt Idx Invest3.44M1.83%-
iShares Russell 2000 ETF2.45M1.30%-
Fidelity Small Cap Index1.13M0.60%15.95K
Vanguard Institutional Extnd Mkt Idx Tr1.13M0.60%-
Biotech Growth Ord1.10M0.59%378.30K
iShares Russell 2000 Growth ETF1.07M0.57%-4.04K
Russell 2000 Index Non-Lendable Fund664.04K0.36%664.04K
Russell 2000 Equity Index Fund B664.04K0.36%664.04K

Recent Insider Transactions


DateNameRoleActivityValue
Aug 20, 2026Aurora Daljit Singh See RemarksSell$101.00K
Aug 21, 2026Aurora Daljit Singh See RemarksSell$33.60K
Aug 20, 2026Aurora Daljit Singh See RemarksSell$102.59K
Aug 21, 2026Aurora Daljit Singh See RemarksSell$32.78K
Aug 17, 2026Aurora Daljit Singh See RemarksSell$86.82K

Insider Transactions Trends


DateBuySell
2026 Q3-11
2026 Q2--
2026 Q1-4
2025 Q431
2025 Q2--

NMRA Ownership FAQ


Who Owns Neumora Therapeutics?

Neumora Therapeutics shareholders are primarily institutional investors at 62.98%, followed by 25.33% insiders and 11.69% retail investors. The average institutional ownership in Neumora Therapeutics's industry, Biotech Stocks , is 181.71%, which Neumora Therapeutics falls below.

Who owns the most shares of Neumora Therapeutics?

Neumora Therapeutics’s largest shareholders are Siren (8.5M shares, 4.59%), Blackrock funding, inc. /de (8.14M shares, 4.40%), and Softbank group (6.09M shares, 3.73%). Together, they hold 12.71% of Neumora Therapeutics’s total shares outstanding.

Does Blackrock own Neumora Therapeutics?

BlackRock is not among the top 10 institutional shareholders of Neumora Therapeutics.

Who is Neumora Therapeutics’s biggest shareholder by percentage of total assets invested?

Mic capital management uk llp is Neumora Therapeutics’s biggest shareholder by percentage of total assets invested, with 0.57% of its assets in 4.46M Neumora Therapeutics shares, valued at 2.66M$.

Who is the top mutual fund holder of Neumora Therapeutics shares?

Vanguard Morn Total Stk Mkt Idx Investor is the top mutual fund holder of Neumora Therapeutics shares, with 1.88% of its total shares outstanding invested in 3.44M Neumora Therapeutics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools